Siga Technologies INC Restricted Cash and Cash Equivalents, Noncurrent
Siga Technologies INC (SIGA) had Restricted Cash and Cash Equivalents, Noncurrent of $2.54 million as of 2020-12-31, per its 10-K filed 2021-03-04.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Restricted Cash and Cash Equivalent, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2021-03-04
- 2020-12-31: Restricted Cash and Cash Equivalents, Noncurrent $2.54M.
- 2020-09-30: Restricted Cash and Cash Equivalents, Noncurrent $6.48M.
- 2020-06-30: Restricted Cash and Cash Equivalents, Noncurrent $11.18M.
- 2020-03-31: Restricted Cash and Cash Equivalents, Noncurrent $16.30M.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent |
|---|---|
| 2020-12-31 | $2.54M 10-K · filed 2021-03-04 |
| 2020-09-30 | $6.48M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $11.18M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $16.30M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $14.15M 10-K · filed 2021-03-04 |
| 2019-09-30 | $87.08M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $64.48M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $66.79M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $68.29M 10-Q · filed 2019-11-05 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-06 |
| 2018-06-30 | $1.70M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $3.75M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $6.54M 10-Q · filed 2018-11-06 |
| 2017-09-30 | $9.43M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $12.09M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $14.81M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $17.33M 10-K · filed 2018-03-06 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-07 |
| 2014-12-31 | $4.00M 10-K · filed 2016-03-04 |
| 2014-09-30 | $4.00M 10-Q · filed 2014-11-04 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |